Please assess the completion status of the following clinical trial:

Trial Title: Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age ≥ 18 years~* Overactive bladder for at least 3 months~* 3 day- voiding diary~  * average urinary frequency ≥ 10 voids/24hrs~ * urgency ≥ 2 episodes/24hrs~* moderate to severe in the Indevus Urgency Severity Scale (IUSS)~Exclusion Criteria:~* clinically significant stress urinary incontinence~* polyuria of more than 3000 ml/24 hrs~* severe hepatic or renal diseases~* contraindications to the use of antimuscarinic drugs~* genitourinary conditions that could cause OAB symptoms such as urinary tract infection, genitourinary malignancy or interstitial cystitis~* uninvestigated hematuria~* clinically significant bladder outlet obstruction~* clinically significant pelvic organ prolapse~* being on a bladder-training program or having been on electrostimulation therapy two weeks before randomization or intention to start~* unstable dosages of drugs with anticholinergic side effects~* any other investigational drug taken up to 2 months prior to randomization~* pregnancy or breastfeeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).